May 20, 5:06 a.m.
Create my watchlists and portfolios login | register
zoom
United States | Healthcare | Biotechnology
Frankfurt: IDIX.FSE at 05/17, 9:35a.m. ET - show other symbols

Idenix Pharmaceuticals

advertisement

Idenix Pharma downgraded to "above average"

10/30/09 - Caris & Company

NEW YORK, October 30 (newratings.com) - Analysts at Caris & Company downgrade Idenix Pharma (IDIX) from "buy" to "above average." The target price has been reduced from $16 to $5.



                                                                                                                        

Make newratings better! How do you like us?